Page 266 - EJMO-9-3
P. 266

Eurasian Journal of
            Medicine and Oncology                                          Metastasis gene expression in colorectal cancer



               Control. 2022;29:1-11.                             impact on colorectal liver metastasis: A  narrative review.
                                                                  Cureus. 2024;16(12):e76079.
               doi: 10.1177/10732748221143879
                                                                  doi: 10.7759/cureus.76079
            4.   Diao YE, Xu Q. CASR rs1801725 polymorphism is
               associated with the risk and prognosis of colorectal cancer:   15.  Zhao L, Hou X, Feng Y,  et al. A  chronic stress-
               A case-control study. J Clin Lab Anal. 2020;34(11):e23463.  induced microbiome perturbation, highly enriched in
                                                                  Ruminococcaceae_UCG-014, promotes colorectal cancer
               doi: 10.1002/jcla.23463
                                                                  growth and metastasis. Int J Med Sci. 2024;21(5):882-895.
            5.   Yi C, Li T, Shen Y,  et al. Polymorphisms of nucleotide      doi: 10.7150/ijms.90612
               excision repair genes associated with colorectal cancer risk:
               Meta-analysis  and  trial  sequential  analysis.  Front Genet.   16.  Shi X, Wang X, Yao W,  et al. Mechanism insights and
               2022;13:1009938.                                   therapeutic intervention of tumor metastasis: Latest
                                                                  developments and perspectives.  Signal Transduct Target
               doi: 10.3389/fgene.2022.1009938                    Ther. 2024;9(1):1-46.
            6.   Nguyen LH, Goel A, Chung DC. Pathways of colorectal      doi: 10.1038/s41392-024-01885-2
               carcinogenesis. Gastroenterology. 2020;158(2):291-302.
                                                               17.  Zhao H, Wu L, Yan G,  et al. Inflammation and tumor
               doi: 10.1053/j.gastro.2019.08.059                  progression: Signaling pathways and targeted intervention.
            7.   Li Q, Geng S, Luo H, et al. Signaling pathways involved in   Signal Transduct Target Ther. 2021;6(1):1-46.
               colorectal cancer:  Pathogenesis  and targeted therapy.  Sig      doi: 10.1038/s41392-021-00658-5
               Transduct Target Ther. 2024;9(1):266.
                                                               18.  Hou S, Zhao Y, Chen J, Lin Y, Qi X. Tumor-associated
               doi: 10.1038/s41392-024-01953-7                    macrophages in colorectal cancer metastasis: Molecular
            8.   Li J, Ma X, Chakravarti D, Shalapour S, DePinho RA.   insights and translational perspectives.  J  Transl Med.
               Genetic and biological hallmarks of colorectal cancer. Genes   2024;22(1):62.
               Dev. 2021;35(11-12):787-820.                       doi: 10.1186/s12967-024-04856-x
               doi: 10.1101/gad.348226.120                     19.  Yang  S,  Li  Y,  Zhang  Y,  Wang  Y.  Impact  of  chronic  stress
            9.   Shweikeh F, Zeng Y, Jabir AR, et al. The emerging role of   on intestinal mucosal immunity in colorectal cancer
               blood-based biomarkers in early detection of colorectal   progression. Cytokine Growth Factor Rev. 2024;80:24-36.
               cancer: A  systematic review.  Cancer Treat Res Commun.      doi: 10.1016/j.cytogfr.2024.10.007
               2024;42:100872.
                                                               20.  Xue C, Chu Q, Shi Q, Zeng Y, Lu J, Li L. Wnt signaling
               doi: 10.1016/j.ctarc.2025.100872                   pathways in biology and disease: Mechanisms and
            10.  Schiliro C,  Firestein  BL.  Mechanisms  of  metabolic   therapeutic advances.  Signal Transduct Target Ther.
               reprogramming in cancer cells supporting enhanced growth   2025;10:106.
               and proliferation. Cells. 2021;10(5):1056.         doi: 10.1038/s41392-025-02142-w

               doi: 10.3390/cells10051056                      21.  Wang H, Wang HS, Zhou BH, et al. Epithelial-mesenchymal
            11.  Pascual  G,  Benitah  SA.  Lipids  in  the  tumor   transition (EMT) induced by TNF-α requires AKT/GSK-
               microenvironment: Immune modulation and  metastasis.   3β-mediated stabilization of snail in colorectal cancer. PLoS
               Front Oncol. 2024;14:1435480.                      One. 2013;8(2):e56664.
               doi: 10.3389/fonc.2024.1435480                     doi: 10.1371/journal.pone.0056664
            12.  Zhang YH, Chen XL, Wang YR, Hou YW, Zhang YD,   22.  Buyuk B, Jin S, Ye K. Epithelial-to-mesenchymal transition
               Wang  KJ. Prevention of malignant digestive system tumors   signaling pathways responsible for breast cancer metastasis.
               should focus on the control of chronic inflammation. World   Cel Mol Bioeng. 2022;15(1):1-13.
               J Gastrointest Oncol. 2023;15(3):389-404.          doi: 10.1007/s12195-021-00694-9
               doi: 10.4251/wjgo.v15.i3.389                    23.  Lu J, Kornmann M, Traub B. Role of epithelial to
            13.  Varghese N, Majeed A, Nyalakonda S, Boortalary T,   mesenchymal transition in colorectal cancer. Int J Mol Sci.
               Halegoua-DeMarzio D, Hann HW. Review of related    2023;24(19):14815.
               factors for persistent risk of hepatitis b virus-associated      doi: 10.3390/ijms241914815
               hepatocellular carcinoma. Cancers (Basel). 2024;16(4):777.
                                                               24.  Ribatti D, Tamma R, Annese T. Epithelial-mesenchymal
               doi: 10.3390/cancers16040777                       transition in cancer: A  historical overview.  Transl Oncol.
                                                                  2020;13(6):100773.
            14.  Kaur A, Azeez GA, Thirunagari M,  et al. Association of
               chronic hepatitis B with colorectal cancer and its dual      doi: 10.1016/j.tranon.2020.100773


            Volume 9 Issue 3 (2025)                        258                         doi: 10.36922/EJMO025210202
   261   262   263   264   265   266   267   268   269   270   271